Literature DB >> 27421662

Functional characterization of an oxytocin receptor gene variant (rs2268498) previously associated with social cognition by expression analysis in vitro and in human brain biopsy.

Martin Reuter1,2, Christian Montag3,4, Steffen Altmann5, Fabian Bendlow6, Christian Elger6,7, Peter Kirsch8, Albert Becker9, Susanne Schoch-McGovern9, Matthias Simon10, Bernd Weber2,6,7, Andrea Felten1,2.   

Abstract

The oxytocin system plays a prominent role in social behavior across species, and numerous genetic studies in humans have reported associations between polymorphisms on the oxytocin receptor (OXTR) gene and phenotypes related to social cognition, affiliation, perspective taking, and sociability in healthy subjects and in patients with atypical social behavior, such as in autism spectrum disorders (ASD). Recently, the first study demonstrating altered agonist-induced OXTR internalization and recycling for the exonic variant rs35062132 emerged. Beside this, there has been no further demonstration of the functionality of the OXTR variants especially there does not exist any for the regulatory units. To address this gap in the literature, we tested the functionality of the promoter flanking single nucleotide polymorphism (SNP) rs2268498, which has proven an interesting candidate for predicting social behavior in recent association studies. Results of genetic expression analyses in human hippocampal tissue showed a twofold difference in messenger RNA transcription, dependent on the presence or absence of the C-allele. This finding was corroborated by cloning, i.e., in vitro reporter gene expression analysis after transfection of OXTR promoter plasmids into HEK-293 cells. Our results underline the importance of OXTR rs2268498 for genetic research in social behavior and ASD.

Entities:  

Keywords:  Oxytocin receptor; functionality; mRNA expression; rs2268498; social behavior

Mesh:

Substances:

Year:  2016        PMID: 27421662     DOI: 10.1080/17470919.2016.1214174

Source DB:  PubMed          Journal:  Soc Neurosci        ISSN: 1747-0919            Impact factor:   2.083


  7 in total

Review 1.  Evolutionary diversity as a catalyst for biological discovery.

Authors:  Zachary V Johnson; Larry J Young
Journal:  Integr Zool       Date:  2018-11       Impact factor: 2.654

2.  Enhanced endogenous oxytocin signaling in the brain modulates neural responses to social misalignment and promotes conformity in humans: A multi-locus genetic profile approach.

Authors:  Minwoo Lee; Adriana Lori; Nicole A Langford; James K Rilling
Journal:  Psychoneuroendocrinology       Date:  2022-07-13       Impact factor: 4.693

Review 3.  Oxytocin and vasopressin neural networks: Implications for social behavioral diversity and translational neuroscience.

Authors:  Zachary V Johnson; Larry J Young
Journal:  Neurosci Biobehav Rev       Date:  2017-05       Impact factor: 8.989

4.  Oxytocin and the stress buffering effect of social company: a genetic study in daily life.

Authors:  Maurizio Sicorello; Linda Dieckmann; Dirk Moser; Vanessa Lux; Maike Luhmann; Wolff Schlotz; Robert Kumsta
Journal:  Soc Cogn Affect Neurosci       Date:  2020-05-19       Impact factor: 3.436

5.  How Oxytocin Receptor (OXTR) Single Nucleotide Polymorphisms Act on Prosociality: The Mediation Role of Moral Evaluation.

Authors:  Siyuan Shang; Nan Wu; Yanjie Su
Journal:  Front Psychol       Date:  2017-03-21

6.  An epistasis between dopaminergic and oxytocinergic systems confers risk of post-traumatic stress disorder in a traumatized Chinese cohort.

Authors:  Kunlin Zhang; Gen Li; Li Wang; Chengqi Cao; Ruojiao Fang; Shu Luo; Ping Liu; Xiang Yang Zhang
Journal:  Sci Rep       Date:  2019-12-17       Impact factor: 4.379

7.  Emotion recognition associated with polymorphism in oxytocinergic pathway gene ARNT2.

Authors:  Daniel Hovey; Susanne Henningsson; Diana S Cortes; Tanja Bänziger; Anna Zettergren; Jonas Melke; Håkan Fischer; Petri Laukka; Lars Westberg
Journal:  Soc Cogn Affect Neurosci       Date:  2018-02-01       Impact factor: 3.436

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.